DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction (FGR) and acute ischemic stroke ...

A new in silico design framework optimizes epi-ddRADseq enzyme pairs and size-selection windows across 75 plant species, ...

Single-molecule experiments reveal that one SauUSI restriction enzyme dimer from Staphylococcus aureus acts as an ATP-driven ...

Tailored immunoassay lines address common lab issues: low detectability, poor reproducibility, limited sample volume ...

In front of the squat rack at the gym, there is someone rubbing their knee.On the bar, there are the same weight plates as ...

An oral enzyme supplement appeared to reduce symptom severity for adults with irritable bowel syndrome (IBS), a prospective, ...

Lee Soo-man, Key Producer and Visionary Leader of A2O Entertainment (hereinafter A2O), who previously served as a producer at ...

It has been discovered that the chain length of lipids that make up cell membranes increases with age, a phenomenon common to ...

Tamara Aydinyan has been traveling the world with the help of miles and points for over a decade and enjoys teaching others to do the same. When she's not on the move, you can find her in Los Angeles ...

An expert at the University of Copenhagen said his team had been sharing its research with the company’s A.I. model, Claude, and that its new finding matched their work. By Carl Zimmer When Anthropic, ...

Anthropic's Claude discovered a novel enzyme system with properties reminiscent of CRISPR. Here is what it found and what remains unknown.